Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
|
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [1] Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer’s disease diagnosis: a retrospective study in a Belgian academic hospital
    Matthieu Deltombe
    Catherine Fillee
    Vincent van Pesch
    Acta Neurologica Belgica, 2022, 122 : 245 - 247
  • [2] Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
    Pannee, Josef
    Portelius, Erik
    Minthon, Lennart
    Gobom, Johan
    Andreasson, Ulf
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (04) : 651 - 658
  • [3] The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
    Niemantsverdriet, Ellis
    Ottoy, Julie
    Somers, Charisse
    De Roeck, Ellen
    Struyfs, Hanne
    Soetewey, Femke
    Verhaeghe, Jeroen
    Van den Bossche, Tobi
    Van Mossevelde, Sara
    Goeman, Johan
    De Deyn, Peter Paul
    Marien, Peter
    Versijpt, Jan
    Sleegers, Kristel
    Van Broeckhoven, Christine
    Wyffels, Leonie
    Albert, Adrien
    Ceyssens, Sarah
    Stroobants, Sigrid
    Staelens, Steven
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 561 - 576
  • [4] Significant discrepancies in amyloid status A plus /A- in CSF based on Aβ1-42 measurement or Aβ1-42/Aβ1-40 ratio.
    Tisserand, C.
    Gouilly, D.
    Benaiteau, M.
    Rafiq, M.
    Nogueira, L.
    Pariente, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 260 - 260
  • [5] Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease
    Shoji, M
    Matsubara, E
    Kanai, M
    Watanabe, M
    Nakamura, T
    Tomidokoro, Y
    Shizuka, M
    Wakabayashi, K
    Igeta, Y
    Ikeda, Y
    Mizushima, K
    Amari, M
    Ishiguro, K
    Kawarabayashi, T
    Harigaya, Y
    Okamoto, K
    Hirai, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (02) : 134 - 140
  • [6] Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease
    Mehta, PD
    Pirttilä, T
    Mehta, SP
    Sersen, EA
    Aisen, PS
    Wisniewski, HM
    ARCHIVES OF NEUROLOGY, 2000, 57 (01) : 100 - 105
  • [7] Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer's disease
    Shao, HY
    Jao, SC
    Ma, K
    Zagorski, MG
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (02) : 755 - 773
  • [8] Interaction between Aβ(1-42) and Aβ(1-40) in Alzheimer's β-amyloid fibril formation in vitro
    Hasegawa, K
    Yamaguchi, I
    Omata, S
    Gejyo, F
    Naiki, H
    BIOCHEMISTRY, 1999, 38 (47) : 15514 - 15521
  • [9] Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
    Colletti, Tiziana
    Agnello, Luisa
    Spataro, Rossella
    Guccione, Lavinia
    Notaro, Antonietta
    Lo Sasso, Bruna
    Blandino, Valeria
    Graziano, Fabiola
    Gambino, Caterina Maria
    Giglio, Rosaria Vincenza
    Bivona, Giulia
    La Bella, Vincenzo
    Ciaccio, Marcello
    Piccoli, Tommaso
    BRAIN SCIENCES, 2021, 11 (03) : 1 - 10
  • [10] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
12345